rs4444903
This is a regulatory region variant variant in the EGF gene.
▶GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
platelet count
mean corpuscular hemoglobin concentration
lymphocyte count
leukocyte quantity
▶ClinVar annotation
▶Research that mentions this SNP (4)
▶Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomasMeta-analysisN=170,737Baiyu Yang et al.(2014)· Molecular Carcinogenesis
A meta-analysis of 78 case-control studies (73,996 cases, 96,741 controls) found that the rs6983267 polymorphism on chromosome 8q24 was significantly associated with increased cancer risk across all genetic models (dominant: OR=1.19, 95% CI=1.13-1.26; recessive: OR=1.19, 95% CI=1.14-1.25; homozygous: OR=1.31, 95% CI=1.23-1.40). Stratified analyses showed significant associations for colorectal cancer, prostate cancer, and thyroid cancer in Caucasians, and lung cancer in Asians.
▶No evidence that associations of incident, sporadic colorectal adenoma with its major modifiable risk factors differ by chromosome 8q24 region rs6983267 genotypeMeta-analysisN=170,737Baiyu Yang et al.(2014)· Molecular Carcinogenesis
Meta-analysis of 78 case-control studies (73,996 cases, 96,741 controls, 170,737 total subjects) examining the association between 8q24 rs6983267 G/T polymorphism and cancer susceptibility. The G risk allele was significantly associated with increased cancer risk across all genetic models (dominant: OR=1.19, 95%CI=1.13-1.26; recessive: OR=1.19, 95%CI=1.14-1.25; homozygous: OR=1.31, 95%CI=1.23-1.40). Significant associations were found for colorectal cancer, prostate cancer, thyroid cancer, and lung cancer in ethnicity-stratified analyses.
▶Xeroderma pigmentosum genes and melanoma riskAssociationN=300Paszkowska-Szczur K. et al.(2013)· International Journal of Cancer
Case-control study of 150 melanoma patients and 150 healthy controls evaluating seven nucleotide excision repair pathway polymorphisms (XPC Lys939Gln and Ala499Val, XPD Lys157Gln/Asp272Asn/Arg751Arg, XPG Asp1104His, XPF Arg415Gln) and cutaneous melanoma susceptibility. None of the polymorphisms showed significant association with melanoma risk in the Iranian population studied.
▶Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With CirrhosisAssociationN=328Kenneth K. Tanabe et al.(2008)· JAMA
The EGF gene rs4444903 (A61G) polymorphism is associated with hepatocellular carcinoma risk in cirrhotic patients through modulation of EGF expression levels. The G/G genotype showed 4.0-fold odds ratio (95% CI, 1.6-9.6; P=.002) for HCC compared with A/A in the Massachusetts cohort (207 patients, 59 HCC cases), with validation in a French alcoholic cirrhosis cohort (121 patients, 44 HCC cases; OR 2.9, P=.045). The G allele exhibits greater mRNA stability and higher EGF secretion in cell lines and tissues.
About EGF
This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
View all EGF variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…